FDA greenlights mRNA flu vaccine, promising faster seasonal updates
The FDA has approved an mRNA-based influenza vaccine that can be reformulated close to the start of flu season.
Why it matters
A faster-updating flu vaccine could improve seasonal protection and reduce illness worldwide.
In this story
mRNA flu vaccineFDA approvalseasonal flu shotvaccine formulationrapid updatetraditional flu vaccineCOVID vaccine technology
